Acute extrapyramidal syndrome and neuroleptical malignant syndrome. A case report;Sindrome extrapiramidale acuta e sindrome maligna da neurolettici

Recenti Progressi in Medicina

Volumn 99, Issue 3, 2008, Pages 146-148

  Cesario, Vincenzo ^a,b  

^a Ospedale di Caprino Veronese   (Italy)

^b NONE   (Italy)

Author keywords

Acute extrapyramiramidal syndrome; Haloperidol; Neuroleptic malignant syndrome

Indexed keywords

BIPERIDEN; DIAZEPAM; FUROSEMIDE; HALOPERIDOL;

ACUTE PSYCHOSIS; ADULT; ARTICLE; CASE REPORT; CYANOSIS; DRUG EFFICACY; DRUG TOLERABILITY; DYSPNEA; EXTRAPYRAMIDAL SYNDROME; HUMAN; HYPERTENSION; MALE; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; RISK FACTOR; SIDE EFFECT; SWEATING; SYMPTOMATOLOGY;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; HALOPERIDOL; HUMANS; INJECTIONS, INTRAVENOUS; MALE; NEUROLEPTIC MALIGNANT SYNDROME; SYNDROME;

EID: 42249114532     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Banerjee A, Basu D. Cardiovascular risk with anti-psychotics: case-control study or survey? Br J Psychiatry 2007; 191: 563.
2. Bellantuono C, Balestrieri M. Gli psicofarmaci: farmacologia e terapia. IV ed. Roma : Il Pensiero Scientifico Editore 1997; 493-4; 509-12.
3. Whitworth AB., Fleishhacker WW. Adverse effects of antipsychotic drugs. Intern Clin Psychopharmacology 1995; 9 (suppl. 5): 21-7.
4. Marsden CD, Jenner P. The pathophysiology of extrapiramidal side-effects of neuroleptic drugs. Psychological Med 1980; 10: 55-72.
5. Addonizio G, et al. Symptoms of neuroleptic malignant syndrome in 82 consecutive impatients. Am J Psychiatry 1986; 143: 1587-90.
6. Birkhimer L, De Vane C. The neuroleptic malignant syndrome: presentatio and treatment. Drug Intell Clin Pharmachology 1984; 18: 728-9.
7. Kellam A.M.P. The (frequently) neuroleptic (potentially) malignant syndrome. Br J Psychiatry 1990; 157: 169-73.
8. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142: 137-45.
9. German E. Berrias. Fish's clinical psychopathology: sign and symptoms in psychiatry. Br J Psychiatry 2007; 191: 462.
10. Pope HG, Keck P, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 1989; 143: 1227-33.
11. Shaley A, Munitz H. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatrics Scand 1989; 73: 337-47.
12. Bellantuono C, et al. I nuovi antipsicotici: efficacia, tollerabilità e modalità d'uso nella pratica clinica. II ed. Roma: Il Pensiero Scientifico Editore 2001; 19-25; 97-105.